Get started
Author

Xiongpeng Zhu

Observed names: Xiong-Peng Zhu, Xiong-peng ZHU, XiongPeng Zhu
ORCID: 0000-0003-4698-2276
Observed ORCID: 0000-0003-4698-2276
OpenAlex ID: A5100722138
FLT3 inhibitors in acute myeloid leukemia
2018 · Mei Wu, Chuntuan Li, et al. · Journal of Hematology & Oncology · 174
PDF
Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
2010 · Xiongpeng Zhu, Yuehua Ma, et al. · Journal of Hematology & Oncology · 61
PDF
Novel agents for chronic lymphocytic leukemia
2013 · Mei Wu, Akintunde Akinleye, et al. · Journal of Hematology & Oncology · 32
PDF
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
2017 · Pengliang Xin, Chuntuan Li, et al. · Drug Design Development and Therapy · 31
PDF
The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
2015 · Chuntuan Li, Pengliang Xin, et al. · Cancer Cell International · 26
PDF
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
2013 · Jiasheng Hu, Xiao Huang, et al. · Cancer Cell International · 17
PDF
Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma
2023 · ChaoFeng Zhang, Qi Lin, et al. · Frontiers in Immunology · 10
PDF
Calreticulin increases growth and progression of natural killer/T-cell lymphoma
2020 · Yan Zheng, Chuntuan Li, et al. · Aging · 10
Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia
2019 · Pengliang Xin, Wenqian Xu, et al. · Cancer Management and Research · 10
PDF
Mesenchymal Stem Cells Immunosuppressed IL-22 in Patients with Immune Thrombocytopenia via Soluble Cellular Factors
2015 · Mei Wu, Hongfeng Ge, et al. · Journal of Immunology Research · 9
PDF
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE
2024 · Keshu Zhou, Tingyu Wang, et al. · Annals of Hematology · 8
Role and mechanism of PTEN in Burkitt's lymphoma
2020 · Chuntuan Li, Yahong Xu, et al. · Oncology Reports · 8
PDF
Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma
2019 · Shengquan Liu, Chuntuan Li, et al. · Medical Science Monitor · 8
Antiproliferative effects of γ-secretase inhibitor, a Notch signalling inhibitor, in multiple myeloma cells and its molecular mechanism of action
2013 · Jiasheng Hu, Xiongpeng Zhu, et al. · Journal of International Medical Research · 8
PDF
Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma
2023 · Chaofeng Zhang, Qi Lin, et al. · Scientific Reports · 7
PDF
Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy
2024 · Chaofeng Zhang, Siting Zhan, et al. · Frontiers in Pharmacology · 6
PDF
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial
2024 · Zhiming Li, Wenqi Jiang, et al. · Journal for ImmunoTherapy of Cancer · 6
PDF
APDL1-CART cells exhibit strong PD-L1-specific activity against leukemia cells
2021 · Qunyi Peng, Xiongpeng Zhu, et al. · Aging · 5
In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells
2008 · Xiong-peng ZHU, Zhi-zhe CHEN, et al. · Chinese Medical Journal · 5
Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma
2024 · Yan Han, Chuntuan Li, et al. · Hematological Oncology · 4
PDF
[Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
2017 · Lun-Huan Zhou, Xiong-Peng Zhu, et al. · PubMed · 4
Role of IRF4 in mediating plasmablast differentiation in diffuse large B-cell lymphomas via mTORC1 pathway
2025 · Jingjing Gao, Chuntuan Li, et al. · Annals of Hematology · 2
PDF
Smo gene silencing: a promising strategy for natural killer/t-cell lymphoma treatment via modulating proliferation and apoptosis
2025 · Shengquan Liu, Shaoxiong Wang, et al. · Molecular Medicine · 1
[Silencing Calreticulin Expression Inhibits Invasion Ability of SNK6 Cells in Vitro via Down-Regulating Expression of VEGF and MMP2/9].
2019 · Yan Zheng, Xiong-Peng Zhu, et al. · PubMed · 1
[Induction of anti-lymphoma cytotoxic T cell effect by dendritic cells transfected with recombinant adenovirus vectors carrying survivin gene].
2007 · Xiong-Peng Zhu, Zhi-Zhe Chen, et al. · PubMed · 1
Works count: 40
Citation count: 453
H-index: 9
I10-index: 9
Year
Topic
Type